Legislators
Bills
Statements
Lobbying
Travel
- Bills
- H.R.4158
H.R.4158: CURE High Drug Prices Act
About This Bill
- This bill was introduced in the 116th Congress
- This bill is primarily about health
- Introduced Aug. 2, 2019
- Latest Major Action Aug. 5, 2019
Bill Sponsor
Bill Version
- Introduced in House - Aug. 2, 2019
Bill Summary
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.
(Source: Library of Congress)
Bill Actions
Date | Description |
---|---|
Aug. 5, 2019 |
Referred to the Subcommittee on Health.
|
Aug. 2, 2019 |
Referred to the House Committee on Energy and Commerce.
|
Aug. 2, 2019 |
Introduced in the House by Chellie Pingree (D-Maine) |